Technical Analysis for AURA - Aura Biosciences, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 7.32 | 3.24% | 0.23 |
AURA closed down 1.39 percent on Monday, April 22, 2024, on 54 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: May 6
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 180 Bearish Setup | Bearish Swing Setup | 3.24% | |
| Stochastic Buy Signal | Bullish | 3.24% | |
| Oversold Stochastic | Weakness | 3.24% | |
| NR7 | Range Contraction | 1.81% | |
| Narrow Range Bar | Range Contraction | 1.81% | |
| Oversold Stochastic | Weakness | 1.81% | |
| Stochastic Reached Oversold | Weakness | 3.68% | |
| Oversold Stochastic | Weakness | 3.68% | |
| MACD Bearish Signal Line Cross | Bearish | 4.13% | |
| Narrow Range Bar | Range Contraction | 0.83% |
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | 30 minutes ago |
| 10 DMA Resistance | 30 minutes ago |
| Up 3% | 30 minutes ago |
| Up 2% | 30 minutes ago |
| Up 1% | 30 minutes ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/06/2024
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform to treat tumors of high unmet need in ocular and urologic oncology. Its AU-011, a VDC candidate, is being developed for the first line treatment of primary choroidal melanoma, a rare disease with no drugs approved. The company also develops AU-011 in additional ocular oncology indications, including choroidal metastases. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Tumor Rare Diseases Melanoma Neoplasms Uveal Melanoma
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Tumor Rare Diseases Melanoma Neoplasms Uveal Melanoma
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 13.5 |
| 52 Week Low | 5.9906 |
| Average Volume | 200,707 |
| 200-Day Moving Average | 8.99 |
| 50-Day Moving Average | 8.06 |
| 20-Day Moving Average | 7.45 |
| 10-Day Moving Average | 7.39 |
| Average True Range | 0.40 |
| RSI (14) | 39.76 |
| ADX | 12.71 |
| +DI | 17.98 |
| -DI | 21.20 |
| Chandelier Exit (Long, 3 ATRs) | 7.55 |
| Chandelier Exit (Short, 3 ATRs) | 8.14 |
| Upper Bollinger Bands | 8.01 |
| Lower Bollinger Band | 6.89 |
| Percent B (%b) | 0.18 |
| BandWidth | 15.08 |
| MACD Line | -0.24 |
| MACD Signal Line | -0.22 |
| MACD Histogram | -0.0172 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 7.41 | ||||
| Resistance 3 (R3) | 7.42 | 7.34 | 7.35 | ||
| Resistance 2 (R2) | 7.34 | 7.26 | 7.33 | 7.33 | |
| Resistance 1 (R1) | 7.21 | 7.21 | 7.17 | 7.20 | 7.32 |
| Pivot Point | 7.13 | 7.13 | 7.11 | 7.12 | 7.13 |
| Support 1 (S1) | 7.00 | 7.05 | 6.96 | 6.99 | 6.86 |
| Support 2 (S2) | 6.92 | 7.00 | 6.91 | 6.85 | |
| Support 3 (S3) | 6.79 | 6.92 | 6.83 | ||
| Support 4 (S4) | 6.78 |
